← All companies

APMD

Apnimed, Inc. Common Stock

APMD Pharmaceutical Preparations EDGAR ↗

$25.00

+3.00 +13.64%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$16.12 – $29.15

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws Aug 3, 2026

Other filings

4 Aug 3, 2026 4 Aug 3, 2026 4 Aug 3, 2026 4 Aug 3, 2026 4 Aug 3, 2026 4 Aug 3, 2026 4 Aug 3, 2026 4 Aug 3, 2026 S-8 Jul 31, 2026 424B4 Jul 31, 2026 EFFECT Jul 30, 2026 3 FORM 3 Jul 30, 2026 S-1MEF Jul 30, 2026 3 Jul 30, 2026 3 Jul 30, 2026 3 Jul 30, 2026 3 Jul 30, 2026 3 Jul 30, 2026 3 Jul 30, 2026 3 Jul 30, 2026 3 Jul 30, 2026 3 Jul 30, 2026 3 Jul 30, 2026 CERT Jul 30, 2026 8-A12B Jul 29, 2026 S-1/A Jul 27, 2026 S-1 Jul 10, 2026 DRS/A Jun 1, 2026 DRS/A Apr 22, 2026 D Item 06b Mar 27, 2026 DRS/A Feb 17, 2026 D/A Item 06b Dec 8, 2025 D/A Item 06b Oct 1, 2025 D Item 06b Sep 24, 2025 D Item 06b Apr 24, 2025 DRS Jul 1, 2024 D Item 06b Nov 8, 2023 D Item 06b Dec 23, 2022 D/A Item 06b Nov 1, 2022